Cancer Special Issue: Early detection and minimal residual disease

Odeny, Beryne

doi:10.1371/journal.pmed.1003794

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the Leukemia collection, the PDX Portal reports the Measurable Residual Disease (MRD) value as an indicator of patient treatment response while for the Osteosarcoma collection, the PDX Portal reports the percentage of tumor necrosis from surgical excision of the primary tumor after neoadjuvant chemotherapy. (9-11) In the Texas Children’s Hospital pediatric liver collection, Alpha-fetoprotein (AFP), a serial clinical measurement, is an early indicator of patient treatment response and is also displayed in the PDX Portal as model search criteria on the respective collection summary page. (12)…”

Section: Methodsmentioning

confidence: 99%

BCM PDX Portal: An Intuitive Web-based Tool for Patient-Derived Xenograft Collection Management, as well as Visual Integration of Clinical and Omics Data

Dowst

McOwiti

Zheng

et al. 2023

Preprint

View full text Add to dashboard Cite

Objective: Mouse Patient-Derived Xenograft (PDX) models are essential tools for evaluating experimental therapeutics. Baylor College of Medicine (BCM) established a PDX Core to provide technical support and infrastructure for PDX-based research. To manage PDX collections effectively, de-identified patient clinical and omics data, as well as PDX-related information and omics data, must be curated and stored. Data must then be analyzed and visualized for each case. To enhance PDX collection management and data dissemination, the BCM Biomedical Informatics Core created the BCM PDX Portal (https://pdxportal.research.bcm.edu/). Materials and Methods: Patient clinical data are abstracted from medical records for each PDX and stored in a central database. Annotations are reviewed by a clinician and de-identified. PDX development method and biomarker expression are annotated. DNAseq, RNAseq, and proteomics data are processed through standardized pipelines and stored. PDX gene expression (mRNA/protein), copy number alterations, and mutations can be searched in combination with clinical markers to identify models potentially useful as a PDX cohort. Results: PDX collection management and PDX selection of models for drug evaluation are facilitated using the PDX Portal. Discussion: To improve the translational effectiveness of PDX models, it is beneficial to use a tool that captures and displays multiple features of the patient clinical and molecular data. Selection of models for studies should be representative of the patient cohort from which they originated. Conclusion: The BCM PDX Portal is a highly effective PDX collection management tool allowing data access in a visual, intuitive manner thereby enhancing the utility of PDX collections.

show abstract

Section: Methodsmentioning

confidence: 99%